Baylor College of Medicine
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Baylor College of Medicine
Takeda’s collaboration with the private UK biotech includes NASH and other liver disorders. Reliance will take on Amazon in the India pharmacy space with acquisition of Netmeds.
New York biotech is partnering with researchers at Columbia, Kansas State and Southern Research to address the pandemic.
AlloVir/Baylor, Soligenix/Hawaii and CEL-SCI/Georgia ink coronavirus collaborations, but deal-making continues in other areas as well, including Asklepios/UNC teaming on a gene therapy for Angelman syndrome and DeMelle licensing a targeted pancreatic cancer drug from Moffitt, among others.
Private Company Edition: Kymera said it will take up to three programs into the clinic by next year. Also, three new life science funds recently launched, including a Gates Foundation-backed accelerator for COVID-19 treatments, and Cell Medica reemerges as Kuur with new funding for CAR-NKT therapies.
- Academic and Research Institutions
- Other Names / Subsidiaries
- Baylor College of Medicine®